Low-dose intramuscular hepatitis B vaccination in medical students: 4-Year follow-up

Infection

Volumn 30, Issue 5, 2002, Pages 303-305

  Erensoy, S ^a   Bilgic A ^a   Arda, B ^b   Ozer O ^c  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b University Medical Faculty   (Turkey)

^c Alsancak State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPAVAX GENE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; MALE; MEDICAL STUDENT; NORMAL HUMAN; VACCINATION;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; RETROSPECTIVE STUDIES; STUDENTS, MEDICAL; TIME FACTORS; VACCINATION;

EID: 0036386973     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-2078-1     Document Type: Article

References (13)

1. Bryan JP, Sjogren MH, Perine PL, Legters LJ: Low-dose intradermal and intramuscular vaccination against hepatitis B. Clin Infect Dis 1992; 14: 697-707.
2. Struve J, Aronsson B, Frenning B, Granath F, von Sydow M, Weiland O: Intramuscular versus intradermal administration of a recombinant hepatitis B vaccine: a comparison of response rates and analysis of factors influencing the antibody response. Scand J Infect Dis 1992; 24: 423-429.
3. Heijtink RA, Knol RM, Schalm SW: Low-dose (2 micrograms) hepatitis B vaccination in medical students: comparable immunogenicity for intramuscular and intradermal routes. J Med Virol 1989; 27: 151-154.
4. Elavia, AJ, Marfatia SP, Banker DD: Immunization of hospital personnel with low-dose intradermal hepatitis B vaccine. Vaccine 1994; 12: 87-90.
5. Söyletir G, Bahçeci E, Akoǧlu E, Soyogül U, Lawrance RA: Clinical evaluation of low dose intradermally administered hepatitis B vaccine: a comparison of plasma-derived and recombinant yeast-derived vaccines. Vaccine 1992; 10: 301-304.
6. Kurugöl Z, Egemen A, Erensoy S, Bilgiç A, Kütükçüler N: Intradermal administration of hepatitis B vaccine in infants and preschool children. Turkish J Pediatr 1997; 39: 483-489.
7. Egemen A, Akşit S, Kurugöl Z, Erensoy S, Bilgiç A, Akilli M: Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children. Vaccine 1998; 16: 1511-1515.
8. Wistrom J, Gustafsson A: Antibody response after intradermal administration of recombinant hepatitis B vaccine in children. Scand J Infect Dis 1990; 22: 621-622.
9. Irving WL, Parson AJ, Kurtz JB, Juel-Jensen BE: Intradermal hepatitis B vaccine. Lancet 1987; 2: 561.
10. Bryan JP, Sjogren MH, Macarthy P, Cox E, Legters LJ, Perine PL: Persistence of antibody to hepatitis B surface antigen after low-dose, intradermal hepatitis B immunization and response to a booster dose. Vaccine 1992; 10: 33-38.
11. Struve J, Aronsson B, Frenning B, Forsgren M, Weiland O: Serocon-version after additional vaccine doses to non-responders to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine. Scand J Infect Dis 1994; 26: 468-470.
12. Struve J, Aronsson B, Frenning B, Forsgren M, Weiland O: Response to a booster dose 18 months after a low anti-HBs response (10-99 IU/l) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine. Infection 1995; 23: 42-45.
13. European Consensus Group on Hepatitis B Immunity: Are booster immunizations needed for lifelong hepatitis B immunity? Lancet 2000; 355: 561-565.